VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DMAA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DMAADrugs Made In America Acquisition Corp. Ordinary Shares
$10.63$358M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDMAAQuarterly Cash Flow

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) quarterly cash flow statement — complete operating, investing & financing history

DMAA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Cash from Operations-91.25K-125.18K137.91K-300.67K-251.24K-106-57.23K-115
Operating CF Margin %--------
Operating CF Growth %63.68%-117994.34%340.98%-261510.01%----
Net Income1.97M-1.76M785.09K3.69M1.25M-279-144.93K-55
Depreciation & Amortization00000000
Stock-Based Compensation00000000
Deferred Taxes00000000
Other Non-Cash Items-2.08M1.64M-729.48K-3.92M-1.49M-69.71K20.3K0
Working Capital Changes22.05K-59.01K82.29K-67.4K-14.89K69.88K67.4K-60
Change in Receivables00000000
Change in Inventory00000000
Change in Payables16K-80.44K99.97K70.17K55.2K000
Cash from Investing00231.15M-231.15M-231.15M000
Capital Expenditures00000000
CapEx % of Revenue--------
Acquisitions--------
Investments242.02M0238.21M235.85M233.59M000
Other Investing000-231.15M0000
Cash from Financing100K130.6K-231.3M231.47M231.4M-63841.23K133
Debt Issued (Net)--------
Equity Issued (Net)0-232.05M00232.05M-638-362.96K0
Dividends Paid00000000
Share Repurchases00000000
Other Financing0231.28M-231.3M231.47M250.82K12387.06K133
Net Change in Cash8.75K5.42K-105-1.27K-428-744-16K18
Free Cash Flow-91.25K-125.18K137.9K-300.67K-251.24K-123-57.23K-115
FCF Margin %--------
FCF Growth %63.68%-101670.73%340.96%-261508.27%----
FCF per Share-0.00-0.010.01-0.01-0.01-0.00-0.01-0.00
FCF Conversion (FCF/Net Income)-0.05x-0.59x0.06x-0.13x-0.20x0.38x0.39x2.09x
Interest Paid00000000
Taxes Paid00000000